Prentice, RL. (2006). Research opportunities and needs in the study of dietary modification and cancer risk reduction: The role of biomarkers. Journal of Nutrition, 136, 2668S-2670S.
Shumaker, S., Legault, C., Rapp, S., Thal, L., Wallace, R., Ockene, J., Hendrix, S., Jones, B., III, Assaf, A., Jackson, N., Kotchen, J., Wassertheil-Smoller, S., and Wactawski-Wende, J. (2003). Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in post-menopausal women. The Women’s Health Initiative Memory Study: A Randomized Controlled Trial. Journal of the American Medical Association, 289, 2652-2662.
Trull, A., Demers, L., Holt, D., Johnston, A., Tredger, M., and Price, C.P. (2002). Biomarkers of disease: An evidence-based approach. Cambridge, England: Cambridge University Press.
Tworoger, S., and Hankinson, S. (2006). Use of biomarkers in epidemiological studies: Minimizing the influence of measurement error in the study design and analysis. Cancer Causes and Control, 17, 889-899.
Wild, C., Andersson, C., O’Brien, N., Wilson, L., and Woods, J. (2001). A critical evaluation of the application of biomarkers in epidemiological studies on diet and health. British Journal of Nutrition, 86, (Suppl.)1, S37-S53.
Women’s Health Initiative Steering Committee. (2004). Effects of conjugated equine estrogen in post-menopausal women with hysterectomy. Journal of the American Medical Association, 291, 1701-1712.
Women’s Health Initiative Study Group. (1998). Design of the Women’s Health Initiative clinical trial and observational study. Controlled Clinical Trials, 19, 61-109.
Writing Group for the Women’s Health Initiative. (2002). Risks and benefits of estrogen plus progestin in healthy post-menopausal women: Principal results from the Women’s Health Initiative. Journal of the American Medical Association, 288, 321-333.